
Arthroplasty
Optimizing TXA administration in bilateral TKA
This report has been verified
by one or more authors of the
original publication.
Knee. 2017 Jan;24(1):100-106
83 patients undergoing bilateral simultaneous total knee arthroplasty were included in this randomized trial to evaluate the comparative efficacy of three different methods of tranexamic acid (TXA) administration. Patients were randomized to receive one pre-operative and two intra-operative intravenous dosages, two intra-operative intravenous dosages, or two intraoperative local applications of TXA. Total blood loss and drain blood loss were evaluated over the first two postoperative days. Patients in the pre-operative and two intra-operative dose group had a significantly lower postoperative drain blood loss on the first day after surgery when compared to the other two groups. Postoperative blood drainage on the second postoperative day did not significantly differ between the three groups, nor did total blood loss based on hemoglobin drop from preoperatively to 5 days postoperatively.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.